Caprock Group, Inc. Johnson & Johnson Transaction History

Caprock Group, Inc.

$2.71 Billion
Q3 2024

A detailed history of Caprock Group, Inc. transactions in Johnson & Johnson stock. As of the latest transaction made, Caprock Group, Inc. holds 74,928 shares of JNJ stock, worth $11.6 Million. This represents 0.45% of its overall portfolio holdings.

Number of Shares

74,928

Previous 69,987 7.06%

Holding current value

$11.6 Million

Previous $10.2 Million 18.7%

% of portfolio

0.45%

Previous 0.42%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 07, 2024	BUY	$145.48 - $167.38 $718,816 - $827,024	4,941 Added 7.06%	74,928 $12.1 Million
Q2 2024 Aug 06, 2024	BUY	$144.38 - $157.78 $3.39 Million - $3.71 Million	23,492 Added 50.53%	69,987 $10.2 Million
Q1 2024 Apr 29, 2024	SELL	$155.22 - $162.74 $221,033 - $231,741	-1,424 Reduced 2.97%	46,495 $7.36 Million
Q4 2023 Jan 18, 2024	SELL	$145.6 - $158.88 $19,364 - $21,131	-133 Reduced 0.28%	47,919 $7.51 Million
Q3 2023 Oct 18, 2023	SELL	$155.75 - $174.48 $44,856 - $50,250	-288 Reduced 0.6%	48,052 $7.48 Million
Q2 2023 Aug 10, 2023	BUY	$154.35 - $166.11 $174,724 - $188,036	1,132 Added 2.4%	48,340 $8 Million
Q1 2023 Apr 26, 2023	BUY	$151.05 - $180.26 $1.61 Million - $1.92 Million	10,667 Added 29.19%	47,208 $7.32 Million
Q4 2022 Jan 23, 2023	SELL	$160.2 - $179.79 $314,953 - $353,467	-1,966 Reduced 5.11%	36,541 $0
Q3 2022 Nov 07, 2022	SELL	$161.33 - $179.52 $11,777 - $13,104	-73 Reduced 0.19%	38,507 $6.29 Million
Q2 2022 Jul 26, 2022	BUY	$168.19 - $186.01 $211,751 - $234,186	1,259 Added 3.37%	38,580 $6.85 Million
Q1 2022 Apr 12, 2022	SELL	$158.14 - $179.59 $595,713 - $676,515	-3,767 Reduced 9.17%	37,321 $6.61 Million
Q4 2021 Jan 18, 2022	SELL	$155.93 - $173.01 $220,485 - $244,636	-1,414 Reduced 3.33%	41,088 $7.03 Million
Q3 2021 Oct 07, 2021	SELL	$161.5 - $179.47 $172,805 - $192,032	-1,070 Reduced 2.46%	42,502 $6.86 Million
Q2 2021 Aug 13, 2021	BUY	$159.48 - $171.07 $811,115 - $870,062	5,086 Added 13.22%	43,572 $7.18 Million
Q1 2021 Apr 29, 2021	SELL	$153.07 - $170.48 $157,968 - $175,935	-1,032 Reduced 2.61%	38,486 $6.33 Million
Q4 2020 Jan 29, 2021	SELL	$137.11 - $157.38 $282,857 - $324,674	-2,063 Reduced 4.96%	39,518 $6.22 Million
Q3 2020 Oct 29, 2020	BUY	$140.38 - $153.83 $997,680 - $1.09 Million	7,107 Added 20.62%	41,581 $6.19 Million
Q2 2020 Aug 05, 2020	BUY	$128.81 - $155.51 $342,763 - $413,812	2,661 Added 8.36%	34,474 $4.85 Million
Q1 2020 Apr 28, 2020	BUY	$111.14 - $153.99 $235,839 - $326,766	2,122 Added 7.15%	31,813 $4.17 Million
Q4 2019 Feb 04, 2020	SELL	$127.5 - $146.44 $310,717 - $356,874	-2,437 Reduced 7.59%	29,691 $4.33 Million
Q3 2019 Oct 31, 2019	SELL	$126.95 - $142.14 $178,110 - $199,422	-1,403 Reduced 4.18%	32,128 $4.16 Million
Q2 2019 Jul 23, 2019	SELL	$131.15 - $144.24 $535,878 - $589,364	-4,086 Reduced 10.86%	33,531 $4.67 Million
Q1 2019 Apr 12, 2019	BUY	$125.72 - $139.79 $128,360 - $142,725	1,021 Added 2.79%	37,617 $5.26 Million
Q4 2018 Jan 29, 2019	BUY	$122.84 - $147.84 $84,145 - $101,270	685 Added 1.91%	36,596 $4.72 Million
Q3 2018 Oct 17, 2018	SELL	$121.58 - $142.88 $169,604 - $199,317	-1,395 Reduced 3.74%	35,911 $4.96 Million
Q2 2018 Jul 23, 2018	SELL	$119.4 - $131.76 $325,245 - $358,914	-2,724 Reduced 6.8%	37,306 $4.53 Million
Q1 2018 Apr 23, 2018	SELL	$125.1 - $148.14 $245,946 - $291,243	-1,966 Reduced 4.68%	40,030 $5.13 Million
Q4 2017 Jan 17, 2018	SELL	$131.22 - $143.62 $672,240 - $735,765	-5,123 Reduced 10.87%	41,996 $6.12 Million
Q3 2017 Oct 23, 2017	BUY	$129.47 - $135.38 $6.1 Million - $6.38 Million	47,119	47,119 $6.13 Million

Others Institutions Holding JNJ

# of Institutions

4,271

Shares Held

1.68B

Call Options Held

17.6M

Put Options Held

14.5M

View Full List

About JOHNSON & JOHNSON

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $406B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

More about JNJ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Caprock Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Caprock Group, Inc. with notifications on news.

Account

Caprock Group, Inc. Johnson & Johnson Transaction History